Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice

Atherosclerosis. 2014 Jun;234(2):401-9. doi: 10.1016/j.atherosclerosis.2014.03.022. Epub 2014 Apr 3.

Abstract

Objective: Effects of progressive substitution of dietary n-3 fatty acids (FA) for saturated FA (SAT) on modulating risk factors for atherosclerosis have not been fully defined. Our previous reports demonstrate that SAT increased, but n-3 FA decreased, arterial lipoprotein lipase (LpL) levels and arterial LDL-cholesterol deposition early in atherogenesis. We now questioned whether incremental increases in dietary n-3 FA can counteract SAT-induced pro-atherogenic effects in atherosclerosis-prone LDL-receptor knockout (LDLR-/-) mice and have identified contributing mechanisms.

Methods and results: Mice were fed chow or high-fat diets enriched in SAT, n-3, or a combination of both SAT and n-3 in ratios of 3:1 (S:n-3 3:1) or 1:1 (S:n-3 1:1). Each diet resulted in the expected changes in fatty acid composition in blood and aorta for each feeding group. SAT-fed mice became hyperlipidemic. By contrast, n-3 inclusion decreased plasma lipid levels, especially cholesterol. Arterial LpL and macrophage levels were increased over 2-fold in SAT-fed mice but these were decreased with incremental replacement with n-3 FA. n-3 FA partial inclusion markedly decreased expression of pro-inflammatory markers (CD68, IL-6, and VCAM-1) in aorta. SAT diets accelerated advanced atherosclerotic lesion development, whereas all n-3 FA-containing diets markedly slowed atherosclerotic progression.

Conclusion: Mechanisms whereby dietary n-3 FA may improve adverse cardiovascular effects of high-SAT, high-fat diets include improving plasma lipid profiles, increasing amounts of n-3 FA in plasma and the arterial wall. Even low levels of replacement of SAT by n-3 FA effectively reduce arterial lipid deposition by decreasing aortic LpL, macrophages and pro-inflammatory markers.

Keywords: Atherosclerosis; Inflammation; LDLR−/−; Lipoprotein lipase; n−3 fatty acids.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / metabolism
  • Antigens, Differentiation, Myelomonocytic / metabolism
  • Aorta / enzymology*
  • Aortic Diseases / blood
  • Aortic Diseases / diet therapy*
  • Aortic Diseases / etiology
  • Aortic Diseases / genetics
  • Atherosclerosis / blood
  • Atherosclerosis / diet therapy*
  • Atherosclerosis / etiology
  • Atherosclerosis / genetics
  • Body Weight
  • Cholesterol, Dietary*
  • Diet, High-Fat*
  • Disease Models, Animal
  • Down-Regulation
  • Fish Oils / administration & dosage*
  • Fish Oils / metabolism
  • Inflammation Mediators / metabolism
  • Interleukin-6 / metabolism
  • Lipids / blood*
  • Lipoprotein Lipase / metabolism*
  • Macrophages / metabolism*
  • Male
  • Mice, Knockout
  • Receptors, LDL / deficiency*
  • Receptors, LDL / genetics
  • Time Factors
  • Vascular Cell Adhesion Molecule-1 / metabolism

Substances

  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 protein, mouse
  • Cholesterol, Dietary
  • Fish Oils
  • Inflammation Mediators
  • Interleukin-6
  • Lipids
  • Receptors, LDL
  • Vascular Cell Adhesion Molecule-1
  • interleukin-6, mouse
  • Menhaden oil
  • Lipoprotein Lipase